The Cost Question Everyone Asks
If you are considering ketamine therapy, cost is probably near the top of your list of concerns — and rightfully so. Ketamine therapy can be a significant financial commitment, and unlike most prescription medications, it is rarely covered by standard health insurance. Understanding the real numbers before you begin treatment helps you plan, budget, and choose the treatment approach that fits both your clinical needs and your financial situation.
This guide provides a transparent, detailed breakdown of what ketamine therapy actually costs across every major treatment type, along with practical strategies for managing those expenses.
IV Ketamine Infusion Costs
IV (intravenous) ketamine infusions are the most established form of clinical ketamine therapy and are typically administered at specialized ketamine clinics. They are also the most expensive option.
Per-Session Pricing
A single IV ketamine infusion typically costs between $400 and $800, with the national average falling around $500 to $600. Pricing varies based on geographic location (major metropolitan areas tend to charge more), clinic overhead and amenities, the experience level of the medical team, and whether the session includes additional services like integration therapy or enhanced monitoring.
Some clinics charge more for the first session because it includes an extended medical evaluation, screening bloodwork, and a longer consultation. First-session fees of $600 to $1,000 are not uncommon.
Initial Treatment Series
Most IV ketamine protocols recommend an initial series of 6 infusions over 2 to 3 weeks. At typical pricing, this translates to a total initial investment of $2,400 to $4,800 for the induction phase alone.
This is the phase where your provider determines whether you are a responder — someone who experiences meaningful improvement from ketamine therapy. Approximately 60 to 70 percent of patients with treatment-resistant depression show significant improvement during this initial series, according to clinical research.
Maintenance Infusions
For patients who respond well to the initial series, periodic maintenance infusions are typically recommended to sustain benefits. The frequency varies by patient, but common schedules include monthly infusions for the first several months, gradually extending to every 6 to 8 weeks, and some patients eventually maintaining with quarterly sessions.
Annual maintenance costs for IV ketamine typically range from $2,400 to $6,000, depending on how frequently you need sessions. Some patients can extend the interval between maintenance infusions over time, which reduces long-term costs.
Total First-Year Cost: IV Ketamine
Combining the initial series and maintenance infusions, expect a first-year total of approximately $5,000 to $10,000 for IV ketamine therapy. This figure can be higher in premium markets or at clinics that include extensive ancillary services.
At-Home Oral Ketamine Costs
At-home oral ketamine programs — typically coordinated through telehealth platforms — have emerged as a more affordable alternative to IV infusions. These programs prescribe sublingual (under-the-tongue) ketamine lozenges or tablets that you take at home, usually with a companion present for safety.
Monthly Program Costs
Most at-home ketamine programs charge a monthly fee of $150 to $400 that includes the initial psychiatric evaluation, the ketamine prescription (usually shipped to your door), ongoing prescriber visits via telehealth, and clinical support between sessions.
Some programs bundle everything into a flat monthly fee, while others break out the medication cost separately. The ketamine medication itself — when prescribed as a compounded sublingual lozenge — typically costs $50 to $150 per month through a compounding pharmacy.
Initial Evaluation
Many telehealth ketamine providers charge a one-time evaluation fee of $200 to $350 for the initial psychiatric assessment. Some programs include this in the first month's fee, while others bill it separately. During this evaluation, the provider determines whether ketamine is appropriate for you and establishes your starting dose.
Treatment Protocol
At-home ketamine protocols vary, but a common approach involves 2 to 3 sessions per week during the first month (induction phase), followed by a reduction to 1 to 2 sessions per week during months two and three, and eventual tapering to a maintenance schedule of 1 to 4 sessions per month.
Total First-Year Cost: At-Home Oral Ketamine
For a typical at-home program, first-year costs range from approximately $2,000 to $5,000, making it significantly more affordable than IV infusions. However, the two approaches are not clinically interchangeable — IV ketamine reaches higher blood levels more quickly and may be more effective for certain patients, particularly those with severe treatment-resistant depression.
Spravato (Esketamine) Costs
Spravato is the brand name for esketamine — a nasal spray form of ketamine that has FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation. It is the only form of ketamine therapy that is commonly covered by insurance.
Without Insurance
Without insurance coverage, Spravato is expensive. The list price is approximately $600 to $900 per session, and the treatment requires administration in a certified healthcare facility with a 2-hour monitoring period afterward.
The initial treatment phase involves twice-weekly sessions for the first month, then weekly sessions for months two through four, and then weekly or every-other-week sessions ongoing. Without insurance, total first-year costs could exceed $20,000 to $30,000.
With Insurance
When covered by insurance, Spravato becomes more accessible. Many commercial insurance plans and Medicare cover Spravato after the patient has documented failure on at least two traditional antidepressants. Out-of-pocket costs with insurance vary widely but typically range from $10 to $200 per session after meeting your deductible, depending on your plan's copay or coinsurance structure.
The manufacturer also offers a patient savings program that can reduce costs for eligible commercially insured patients.
Total First-Year Cost: Spravato
With insurance: $500 to $5,000 depending on your coverage and deductible. Without insurance: $20,000 to $30,000 or more — making it the least affordable option without coverage.
Intramuscular (IM) Ketamine Costs
Intramuscular ketamine injections are offered at some clinics as an alternative to IV infusions. The per-session cost is generally lower — typically $300 to $600 — because the administration is simpler and does not require an IV setup.
IM ketamine produces effects similar to IV infusions, with a slightly different onset and duration profile. Some providers offer IM injections as a more cost-effective way to access clinical ketamine in an office setting.
First-year costs for IM ketamine are typically comparable to the lower end of IV infusion pricing: $4,000 to $8,000 including the initial series and maintenance.
Hidden Costs to Consider
When budgeting for ketamine therapy, account for costs beyond the sessions themselves.
Initial evaluation fees may be billed separately from treatment sessions, adding $200 to $500 to your upfront costs.
Lab work or medical clearance may be required before starting treatment, particularly if you have cardiovascular risk factors. If your insurance does not cover these labs, expect $100 to $300.
Transportation costs for in-person treatment should not be overlooked. You cannot drive after a ketamine session, so factor in rideshare costs, a companion's time, or taxi fares for each visit.
Lost work time is a real cost for many patients, especially during the intensive initial phase of IV infusions when you may need 6 sessions in 2 to 3 weeks, each requiring several hours including travel and recovery.
Integration therapy, if not included in your program, adds $100 to $250 per session. While not strictly required, many clinicians consider it an important component for maximizing and sustaining treatment benefits.
Strategies for Reducing Costs
Payment Plans and Financing
Many ketamine clinics offer payment plans or work with medical financing companies that allow you to spread costs over several months. Interest rates vary, so read the terms carefully before committing.
Package Pricing
Some clinics offer discounted rates when you purchase a package of sessions upfront — typically 10 to 20 percent off the per-session price. This can produce meaningful savings if you are confident you will complete the full treatment course.
HSA and FSA Accounts
Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) can be used to pay for ketamine therapy in many cases, since it is a legitimate medical treatment prescribed by a licensed provider. Check with your plan administrator to confirm eligibility, and keep detailed receipts.
Insurance Appeals for IV Ketamine
While most insurance plans do not routinely cover IV ketamine, some patients have successfully appealed denials, particularly when they can document failure on multiple traditional antidepressants, a letter of medical necessity from their prescribing provider, and clinical evidence supporting ketamine for their specific diagnosis. Success rates for these appeals vary, but it is worth attempting if cost is a significant barrier.
Comparing Treatment Models
If IV infusions are financially out of reach, discuss at-home oral ketamine programs with your provider. While the clinical experience is different, research supports the efficacy of oral and sublingual ketamine for many patients, and the cost difference is substantial.
Is Ketamine Therapy Worth the Cost?
This is a deeply personal question that depends on your financial situation, the severity of your condition, and how you have responded to other treatments. A few perspectives may help frame the decision.
For many patients with treatment-resistant depression, the cost of ketamine therapy is comparable to or less than the cumulative cost of years of medications that did not work, the lost productivity and wages associated with untreated or poorly treated depression, and the emergency medical costs that severe depression can generate.
Research consistently shows that approximately 60 to 70 percent of patients with treatment-resistant depression experience significant improvement with ketamine therapy. For those patients, the return on investment — measured in quality of life, functional capacity, and reduced healthcare utilization — is substantial.
That said, ketamine therapy is not a guarantee, and the financial burden is real. Having an honest conversation with your provider about costs, expectations, and what a realistic treatment timeline looks like is essential before you begin. For more on navigating the financial side, see our guides on insurance coverage and affordable ketamine treatment.
References
- Cost-Effectiveness of Ketamine for Treatment-Resistant Depression — Analysis of ketamine treatment costs relative to clinical outcomes and healthcare utilization
- Rapid-Acting Antidepressants: Mechanisms and Clinical Outcomes — NIH review covering ketamine response rates and treatment protocols
- Comparison of IV and Intranasal Ketamine for Treatment-Resistant Depression — Comparative study of different ketamine administration routes and associated costs
- NIMH: Depression Overview — NIMH resource on depression treatment options including emerging therapies
- Mayo Clinic: Esketamine Nasal Spray for Treatment-Resistant Depression — Mayo Clinic overview of Spravato coverage and treatment protocols